ertugliflozin
Showing 1 - 8 of 8
Type 2 Diabetes Trial (Ertugliflozin, Placebo, Glycemic Rescue)
Completed
- Type 2 Diabetes Mellitus
- Ertugliflozin
- +2 more
- (no location specified)
Sep 9, 2022
Mitral Valve Insufficiency, Left Ventricular Systolic Dysfunction Trial in Seoul (Ertugliflozin, Placebo)
Recruiting
- Mitral Valve Insufficiency
- Left Ventricular Systolic Dysfunction
- Ertugliflozin
- Placebo
-
Seoul, Korea, Republic of
- +2 more
Jun 19, 2022
Heart Failure With Reduced Ejection Fraction, Congestion Trial in New York (Ertugliflozin, Placebo)
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- Congestion
- Ertugliflozin
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 29, 2021
Heart Failure With Nonischemic Cardiomyopathy Trial in Seoul (Ertugliflozin, Placebo)
Not yet recruiting
- Heart Failure With Nonischemic Cardiomyopathy
- Ertugliflozin
- Placebo
-
Seoul, Korea, Republic ofSeverance Hospiatal
Aug 5, 2020
Type 2 Diabetes Trial (Ertugliflozin, Placebo to Ertugliflozin)
Completed
- Type 2 Diabetes Mellitus
- Ertugliflozin
- Placebo to Ertugliflozin
- (no location specified)
May 28, 2020
Hypertension, Diabetes, Type 2 Trial in Los Angeles (drug, device, other)
Withdrawn
- Hypertension
- Diabetes Mellitus, Type 2
- Ertugliflozin
- +6 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jan 10, 2020
Diabetes, Type 2 Trial (Ertugliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Ertugliflozin
- Placebo
- (no location specified)
May 19, 2016
Type 2 Diabetes (T2DM) Trial (Ertugliflozin)
Completed
- Type 2 Diabetes Mellitus (T2DM)
- Ertugliflozin
- (no location specified)
Mar 22, 2016